TRANSPARENCY BEFORE TRUST

Sources & editorial policy.

Updated 4 September 2026. This is an educational demonstration, not a clinically validated decision aid.

What has—and hasn’t—been reviewed

Primary-source research informed the market context, audience assumptions and priority safety corrections. Independent clinical review of the complete catalogue is still pending. No named clinician has signed off these guides, and their evidence has not been graded. References support specific regulatory, safety or market statements; they do not verify every efficacy claim or illustrative range.

A licensed clinician must assess individual suitability. Device, product and intended-use approvals vary by country. FDA clearance or approval of one product does not validate all products, all treatment sites or combination treatments.

Safety sources

• FDA: RF microneedling safety communication, 15 October 2025. Serious reported complications are disclosed in guides, comparisons and agent responses.
• FDA: Microneedling devices. Device and combination-treatment limits.
• FDA: Dermal fillers. Approved uses, vascular risks and non-approved sites.
• FDA: Regenerative medicine and exosome alert. No FDA-approved exosome products.
• AAD: Skin conditions lasers can treat. Skin-tone considerations and qualified care.
• FDA: Breast implant risks. Implants are not lifetime devices.
• ASPS: Patient safety. Credentials, facilities and informed decisions.

Market research, not medical advice

• ASPS 2025 report release, 1 September 2026. Neuromodulators and HA fillers make up 80% of minimally invasive procedures; ages 36–55 account for nearly half of cosmetic procedures and ages 66+ showed the largest growth. These are report-level patterns, not this site’s analytics.
• AmSpa 2024 medical-spa report recap. Reports 89% female patients; among female patients, 54% are ages 35–54. The medical-spa survey is a different sample from ASPS and should not be combined as one market estimate.
• ISAPS Global Survey 2024. International plastic-surgeon-reported procedure volumes, not unique patients or every aesthetics provider. Botulinum toxin and HA fillers lead its non-surgical categories.

We infer a useful primary design audience of busy midlife adults, predominantly women, while including men, older adults, varied skin tones and people new to aesthetics. This is a research-informed hypothesis—not validated user research. Popularity never determines whether a treatment is safe or suitable.

How the guide behaves

Search uses transparent catalogue tags and wording, not a clinical assessment or a language-model diagnosis. It may miss a synonym or an option not covered here. Relative cost symbols are editorial estimates, not local price quotes. The catalogue does not accept paid placement, advertise verified providers or offer appointment booking in this demo.

Interactive WebMCP tools use the same actions and content as human controls. They cannot book, pay, submit a patient photo or make medical decisions. Calls and page outcomes are shown in the activity log. The “show_before_after” legacy tool opens a labelled schematic, not a real patient result.

Privacy, imagery and accessibility

The guide does not collect photos, health profiles or accounts. Search, comparison and consultation selections remain in page memory and reset on reload. Your hosting sign-in, browser and AI provider operate under their own data policies. External reference links open a new tab.

The home portrait is AI-generated editorial imagery, not patients or treatment results. The optional anatomy uses one head scan and schematic tissue layers; it cannot represent all faces, skin tones or outcomes. Written guides and keyboard controls provide alternatives to 3D.

The interface is designed for keyboard use, reflow, reduced motion and readable comparisons. No claim of WCAG certification or complete screen-reader compatibility is made. English is currently the only supported content language.

Corrections and the next review gate

Report a correction with the guide URL, the sentence and a supporting primary source. A formal clinical editor, evidence grading, review cadence, translated content and patient/user usability research are still needed before a public clinical-information launch.

3D attribution: Lee Perry-Smith scan, Infinite Realities, CC BY 3.0, adapted for illustrative anatomy. Three.js is MIT-licensed. See the project README for implementation and testing evidence.